Caption Management, LLC Vertex Pharmaceuticals Inc Transaction History

Caption Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $1.42 Million - $1.55 Million	3,480 New	3,480 $1.45 Million
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $11.4 Million - $14.1 Million	-48,358 Closed	0 $0
Q1 2022 May 13, 2022	BUY	$221.42 - $260.97 $9.29 Million - $10.9 Million	41,958 Added 655.59%	48,358 $12.6 Million
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $601,834 - $759,730	-3,400 Reduced 34.69%	6,400 $1.41 Million
Q3 2021 Nov 12, 2021	BUY	$181.39 - $202.99 $1.78 Million - $1.99 Million	9,800 New	9,800 $1.78 Million

1,717

226M

1.19M

1.56M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $133B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Caption Management, LLC with notifications on news.